5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genome-wide association study (GWAS) of cisplatin-related hearing loss in testicular cancer survivors (TCS) to reveal associated variant in Wolfram syndrome 1 (WFS1) gene
    Meeting Abstract

    Wheeler, H. E.; Frisina, R. D.; Gamazon, E. R.; El Charif, O.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C.; Fung, C.; Einhorn, L. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Baseline lactate dehydrogenase (LDH) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with everolimus (EVE) versus sunitinib (SUN): Predictive biomarker analysis from the RECORD-3 trial
    Meeting Abstract

    Voss, M. H.; Chen, D.; Marker, M.; Knox, J.; Hsieh, J.; Voi, M.; Motzer, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types
    Meeting Abstract

    Teo, M.; Zabor, E. C.; Iyer, G.; Bambury, R.; Boyd, M. E.; Rosenberg, J. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)
    Meeting Abstract

    Sweeney, C.; Xie, W.; Regan, M. M.; Nakabayashi, M.; Buyse, M. E.; Clarke, N. W.; Collette, L.; Dignam, J. J.; Fizazi, K.; Habibian, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Serial next generation sequencing (NGS) of cell free DNA (cfDNA) and clonal evolution of AKT1 E17K mutant tumors: Analyses from patients (pts) enrolled on a phase I basket study of an AKT inhibitor (AZD5363)
    Meeting Abstract

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, S. D.; You, D.; Samoila, A.; Schiavon, G.; Li, B. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase VII CheckMate 032 study
    Meeting Abstract

    Sharma, P.; Bono, P.; Kim, J. W.; Spiliopoulou, P.; Calvo, E.; Pillai, R. N.; Ott, P. A.; De Braud, F. G.; Morse, M. A.; Le, D. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
    Meeting Abstract

    Sanford, N. N.; Chen, M. H.; Loffredo, M. J.; Renshaw, A. A.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • AR-V7 and CTC heterogeneity biomarkers additively to predict patient (pt) outcomes with taxanes relative to approved AR targeted therapy
    Meeting Abstract

    Scher, H. I.; Graf, R.; Schreiber, N. A.; McLaughlin, B.; Lu, D.; Louw, J.; Jendrisak, A.; Greene, S.; Rodriguez, A.; Dugan, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Rosenberg, J. E.; Heath, E. I.; Van Veldhuizen, P. J.; Merchan, J. R.; Lang, J. M.; Ruether, J. D.; Petrylak, D. P.; Sangha, R. S.; Smith, D. C.; Sridhar, S. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save